No Data
No Data
[Broker Focus] Soochow Securities has initiated a 'Buy' rating for CHINA FEIHE (06186), indicating that alongside the continuous innovation of the Star Flying Sail, the potential for ultra-high-end products is promising.
Jinwu Finance News | Soochow Securities pointed out that CHINA FEIHE (06186) is one of the earliest infant formula companies in China, focusing on infant formula business. The effects of the channel reform in 2024 are becoming apparent, and the push for ultra-high-end products is driving improvements in the company's revenue and Net income year-on-year, with a performance inflection point emerging. Currently, the company has ample Cash / Money Market on hand, with the dividend rate increasing to 76% in 2024, highlighting its high dividend attribute. The report indicates that as policy standards tighten, the elimination of small brands is leading to increased industry concentration, with China's infant formula CR5 rising from 35% in 2015 to 66% in 2024. Since 2019, CHINA FEIHE has surpassed Nestlé to become the leader in China's infant formula market.
CHINA FEIHE (06186.HK): After a thousand sails have passed, the cranes call out in the marshes.
Investment highlights include a high-dividend domestic infant formula leader, with a performance turning point emerging in 2024. The company is one of the earliest milk powder enterprises in China, focusing on the infant formula business, with the effects of channel reform in 2024 and the push of ultra-premium products driving company revenue and Net income.
CHINA FEIHE (06186.HK) invests 0.15 billion RMB to subscribe to financial products.
CHINA FEIHE (06186.HK) announced that on May 8, its wholly-owned subsidiary Heilongjiang Feihe used idle funds to purchase financial products issued by Shanghai Pudong Development Bank amounting to 0.15 billion yuan. To date, the total principal amount of wealth management and structured deposit financial products purchased by the group from Shanghai Pudong Development Bank that have not yet matured is 2.15 billion yuan.
China Feihe Limited Enhances Capital Gains With SPD Bank Investment
Brokerage morning meeting highlights: The summer movie box office is expected to show year-on-year improvement, Bullish on the full year's box office performance.
In today's Brokerage morning meeting, China International Capital Corporation pointed out that the Federal Reserve will not lower interest rates in the short term; China Securities Co.,Ltd. believes that future fertility subsidies may be improved in three dimensions; Galaxy Securities stated that the box office for summer blockbusters is expected to see a year-on-year improvement, Bullish on the annual box office performance.
J.P. Morgan: Attention and Trade activities in China’s Dairy industry have increased, and Yili's recovery path is clear.
JPMorgan stated that due to the government's policies on infant formula, and the Industry having strong domestic characteristics, it has gradually received more attention since the beginning of the year.